Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
about
Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women.Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs studyAntiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markersMolecular mechanisms of liver fibrosis in HIV/HCV coinfectionA higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patientsFactors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAARTAssessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.Risky alcohol use and serum aminotransferase levels in HIV-infected adults with and without hepatitis C.Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in womenPregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy.The association of HIV viral load with indirect markers of liver injury.Human immunodeficiency virus infection and the liverHepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.Elevated alanine aminotransferase in antiretroviral-naïve HIV-infected African patients: magnitude and risk factors.Hepatitis B virus / human immunodeficiency virus co-infection and its hepatocarcinogenic potential in sub-saharan black africans.Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis virusesIncidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infectionHepatotoxicity and associated risk factors in HIV-infected patients receiving antiretroviral therapy at Felege Hiwot Referral Hospital, Bahirdar, EthiopiaCopenhagen comorbidity in HIV infection (COCOMO) study: a study protocol for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark.Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients.Liver involvement in human immunodeficiency virus infection.Elevated alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus coinfection.Prevalence and Clinical Spectrum of Liver Disease in Nepalese HIV-Sero-Positive Patients Undergoing Antiretroviral Therapy: A Cross-Sectional Hospital Based Study.Antitubercular therapy induced liver function tests abnormalities in human immunodeficiency virus infected individuals.Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome.HIV Infection and TLR Signalling in the Liver.Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs.Response to 'Is AST-to-platelet ratio index a reliable tool in HIV patients in Africa?'.Serological survey of viral hepatitis markers among newly diagnosed patients with HIV/AIDS in China.Low prevalence of chronic hypertransaminasemia in a cohort of HIV-infected patients with no coinfections.Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus.Severe transaminitis after interferon-ribavirin therapy in HIV/HCV-coinfected patients: influence of a sustained HCV response.
P2860
Q30387567-C6A8B9F5-DDF6-4FBF-824A-F1165E05685DQ30574483-6B901CE4-C50C-499B-BE0A-3010F7F3AD79Q31050092-38FE7078-92AA-424B-92E7-0B75EEFFB9A7Q33621724-468D688A-2E9F-4377-BEB2-77E63145BE78Q33907429-EA7915AC-8622-4F64-9F4D-570B0763344DQ33999798-44ED3CC8-D657-4C31-842F-EEC455C9023DQ34070485-4BEF2E48-CCF8-400C-BDC5-B31844F095B3Q34209648-A0DF6C72-11CF-43A1-AA44-4B8920AC8B03Q34577683-567626C7-731A-4690-8097-52BAF11D6737Q35012716-DC0BE7DB-1712-497D-84AB-DD2E449D1D94Q35019825-9E9D05AB-3D35-4020-B250-79E533E52A0CQ35629349-3B3C77D2-969D-4C26-8914-DF9E32D29D16Q35681714-CF4C4DDB-D39C-481C-9276-5F907714B337Q35875848-A1B06AD3-CB80-4182-BDE5-508BBE8F0A9FQ35980098-4F786CD7-E1E3-466E-853B-88635B5BDBC8Q36080888-B098CF65-66FC-455B-BAA2-9F5AAF40197FQ36407167-090261F2-D010-4763-BF72-790AF7CFDB54Q36723335-CD1EE5EF-D9DA-430D-B63C-6E1AEE80D58CQ36759898-D083265F-0352-4B5C-BC0F-E523E3553310Q37056681-61D4DDEA-0C9D-4C23-B3C4-E831360871AFQ37357476-71528110-7CDF-4870-B04F-389FB8C1931AQ37442717-3573ED16-4967-444B-8883-A3D766374343Q37784777-3CE18F17-9476-45B0-82DC-E4D6B2D017CCQ37960564-12A22F93-9C83-4959-9C97-07666D96A670Q38852184-906C5DB7-C3D2-43A6-B44C-F8B4E1F73D7FQ38914756-25863167-282B-4F96-9CD8-E17E4D95DCDFQ40140544-A06C7C7C-2904-4EC0-834D-F619D6520038Q40358004-FA5700DE-7507-4E55-9D06-3A38D104C6C6Q40750320-13042BA9-BAC3-4F2F-852A-828810AAE4B5Q41490253-D17DE4A1-BE33-40B5-8658-4B497CC47079Q41814282-C77C6268-9EDB-423C-8F83-A615E6A39F69Q42269060-EBFD0E13-A6C7-40AF-AC0A-7D39EC9E002CQ42408589-A14BC366-3A14-4317-B51A-296DC9F49EF5Q44174121-82A8C44E-C12C-4C70-B670-55FF9F8B4CFCQ44912567-DA71B3BB-8AC4-4D73-BF7B-5F2FECE5C94CQ45364058-3F28F3C7-5A4E-457A-89E5-65AE10B3AABDQ50552164-C0E32406-F320-4113-BCBB-A9F20FBA895C
P2860
Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Incidence and risk factors for ...... tis b or c virus co-infection.
@en
Incidence and risk factors for ...... tis b or c virus co-infection.
@nl
type
label
Incidence and risk factors for ...... tis b or c virus co-infection.
@en
Incidence and risk factors for ...... tis b or c virus co-infection.
@nl
prefLabel
Incidence and risk factors for ...... tis b or c virus co-infection.
@en
Incidence and risk factors for ...... tis b or c virus co-infection.
@nl
P2093
P50
P356
P1476
Incidence and risk factors for ...... tis b or c virus co-infection.
@en
P2093
Alain Kenfak Foguena
Andri Rauch
Bruno Ledergerber
Helen Kovari
Nicolas J Mueller
Pietro Vernazza
Rainer Weber
P304
P356
10.1086/649922
P407
P577
2010-02-01T00:00:00Z